A near-maximal dose (20 ng/ml) of synthetic luteinizing hormone(LH)-releasing hormone/follicle-stimulating hormone(FSH)-releasing hormone added to incubated anterior pituitary tissue of male rats leads to concomitant increases of intracellular concentrations of adenosine 3': 5'-monophosphate and of release of both LH and FSH. The stimulatory effect of LH-releasing hormone/ FSH-releasing hormone is observed after a lag period of about 90 min and is progressive at later time intervals; a 3-fold stimulation of cAMP accumulation over control is seen after 210 min of incubation. Half-maximal stimulation of cAMP accumulation is observed between 0.1 and 1.0 ng/ml (0.1-1 nM) of LH-releasing hormone/FSH-releasing hormone. In the presence of 10 mM theophylline, the stimulatory effect of LH-releasing hormone/FSH-releasing hormone on cAMP accumulation is similar to that observed in the absence of the inhibitor of cyclic nucleotide phosphodiesterase, indicating that the releasing hormone exerts its effect by specific activation of adenylate cyclase in LH-and FSH-secreting cells rather than by inhibition of cyclic nucleotide phosphodiesterase. Since the release of growth hormone, thyrotropin, prolactin, and adrenocorticotropic hormone is not affected by LH-releasing hormone/FSH-releasing hormone, and since cAMP stimulates the release of all six adenohypophyseal hormones. the observed changes of cAMP concentrations indicate specific stimulation of adenylate cyclase activity in LHand FSH-secreting cells of the adenohypophysis.
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Secretion of luteinizing hormone (LH) and of follicle-stimulating hormone (FSH) by the anterior pituitary gland is controlled by a neurohormone released from the hypothalamic area and carried to its specific adenohypophyseal site of action by a portal blood system (1) (2) (3) (4) . Recently, after more than 10 years of research in many laboratories, this neurohormone was isolated from porcine (5-7) and ovine (8) hypothalami and characterized as a decapeptide having the following structure: (pyro)Glu-His-Try-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (9) (10) (11) . Since this peptide stimulates the release of both LH and FSH under various experimental conditions (4-8, 10-13), it has been called the LH-releasing hormone/FSH-releasing hormone (4, 5, 7) or the gonadotropin-releasing factor (12) . The availability of synthetic LH-releasing hormone/FSHreleasing hormone (14) (15) (16) and of its analogs is of obvious importance for studies of the mechanism of action of this neurohormone in the adenohypophysis.
There was suggestive evidence for a role of adenosine 3': 5'-cyclic monophosphate (cAMP) as a mediator of the action of LH-releasing hormone/FSH-releasing hormone. These studies pertained to reported stimulatory effects of N6,2'.-Odibutyryl cAMP and theophylline (17) and of cAMP itself (18) on LH release and of the dibutyryl derivative of cAMP on FSH release (19) . Recently, a stimulatory effect of the N6-monobutyryl derivative and of various other derivatives of cAMI on the release of both LH and FSH from rat anterior pituitaries in vitro has been observed (G. Chavancy and F. Labrie, unpublished) . Moreover, crude hypothalamic extracts stimulate adenohypophyseal adenylate cyclase activity and concomitant release of LH (20, 21) . However, definitive proof of the role of the adenylate cyclase system as mediator of the action of LH-releasing hormone/FSH-releasing hormone could be obtained only by measurements of adenohypophyseal adenylate cyclase activity or cAMP concentrations under the influence of the purified or synthetic neurohormone. This paper shows that synthetic LH-releasing hormone/FSHreleasing hormone leads to parallel stimulation of accumulation of adenohypophyseal cAMP and of release of both LH and FSH, and indicates that the neurohormone exerts its effects on cAMP by specific activation of adenylate cyclase in LH-and FSH-secreting cells rather than by inhibition of cyclic nucleotide phosphodiesterase.
MATERIALS AND METHODS
Preparation of Hemipituitaries. Anterior pituitaries from male Sprague-Dawley rats (225-250 g) were used throughout these studies. Experiments were always begun between 8: 00 and 9: 00 a.m. to eliminate a possible diurnal variation of the activity and sensitivity of LH-and FSH-secreting cells. After rapid removal of the posterior and intermediary lobes, the anterior pituitary was separated at the isthmus into identical halves. Each hemipituitary from the same animal was used, respectively, as control and experimental. From three to five pituitary halves were used in each group.
Incubation Procedure. Adenohypophyseal tissue was first incubated for 60 min at 370 in an atmosphere of 5% C02-95% 02 in 1.0 ml of Krebs Ringer bicarbonate buffer containing 11 mM 1-glucose (KRBG) as described (22 10. method (14) and extensively purified (23) . The sample used was homogeneous by thin-layer chromatography and electrophoresis and had maximal biological activity (23) .
Assay of cAMP. cAMP was extracted from adenohypophyseal tissue with 5% trichloroacetic acid and measured by the receptor-binding assay of Gilman (24) (33) . Porcine adrenocorticotropic hormone (Mann-Schwartz) was used as standard. Growth hormone was also measured by densitometry of the proteins of the incubation medium separated by polyacrylamide gel electrophoresis (22, 34, 35) . Thyrotropin was measured by bioassay (36) . After appropriate corrections (37) , the results were computed according to Gaddum's procedure (38) for threepoint assays. Independent potency estimates obtained from four assays were tested for homogeneity (39) before calculation of weighted estimate and standard error (40) 
RESULTS

Incremental Release of LH Induced by Various Doses of LH-
Releasing Hormone/FSH-Releasing Hormone. Fig. 1 shows that, under our experimental conditions, a dose of 5 or 10 ng/ml of synthetic LH-releasing hormone/FSH-releasing hormone leads to in vitro stimulation of LH release during the third and fourth 45-min incubation periods. A dose of 0.5 ng/ ml of the neurohormone causes a slight stimulation of LH release, but the effect is observed only after a further lag period of 45 min. Similar results were obtained for FSH release (data not shown). The degree of stimulation of LH release was of similar magnitude with the two higher doses of LH-releasing hormone/FSH-releasing hormone used. Since we have observed that derivatives of cAMP lead to rapid stimulation of LH and FSH release (G. Chavancy and F. Labrie, unpublished), these data on the time-course of the effect of LHreleasing hormone/FSH-releasing hormone on LH and FSH release ( Fig. 1) suggested that important changes of cAMP concentrations in LH-and FSH-secreting cells were more likely to occur after 90 min of incubation in the presence of the neurohormone. A preliminary incubation of 180 min in the presence or absence of LH-releasing hormone/FSH-releasing hormone was therefore adopted for the following experiment.
Effect of Increasing Doses of LH-Releasing Hormone/FSHReleasing Hormone on Adenohypophyseal cAMP Concentration and LH Release. LH-releasing hormone/FSH-releasing hormone concentrations below 0.1 ng/ml do not significantly alter the concentration of adenohypophyseal cAMP ( Fig. 2A) . However, a 160% increase over control of cAMP accumulation is observed at a dose of 5 ng/ml, and a further progressive increase up to 250% (over control) is measured at a concentration of 100 ng/ml of LH-releasing hormone/FSH-releasing hormone ( Fig. 2A) . Fig. 2B shows that the dose-response curve of LH release to increasing concentrations of LH-releasing hormone/FSH-releasing hormone follows closely the observed changes of intracellular concentrations of cAMP. The LH-releasing hormone/FSH-releasing hormone concentration required for a half-maximal effect on both cAMP accumulation and LH and FSH release is between 0.1 and 1.0 ng/ ml or between 0.1 and 1 nM.
Comparative Time-Courses of the Effects of LH-Releasing Hormone/FSH-ReleasingHormone onAdenohypophyseal cAMP Accumulation and on LH and FSH Release. Fig. 3A shows that in the presence of a nearly maximal dose of LH-releasing hormone/FSH-releasing hormone (20 ng/ml), the first significant rise of the cAMP concentration (50% over control) can be detected after 120 min of incubation. Longer periods of incubation in the presence of releasing hormone lead to progressive increases of the cAMP concentrations; a 4-fold stimulation over control is measured after 210 min of incubation (Fig. 3A) . The release of both LH and FSH follows very closely the changes of cAMP concentrations, a significant increase of gonadotropin release being detected at 120 min and progressive rise of the rates of release of both hormones being measured at longer time intervals (Fig. 3B) .
Effect of Theophylline on Stimulation of cAMP Accumulation by LH-Releasing Hormone/FSH-Releasing Hormone. When Proc. Nat. Acad. Sci. USA 69 (1972) 80L 10 mM of theophylline, an inhibitor of cyclic nucleotide phosphodiesterase, was present in both control and experimental groups (Fig. 4) Synthetic LH-Releasing Hormone and cAMP 2679 leasing hormone on cAMP accumulation had characteristics similar to those observed in the absence of theophylline (Fig.  3A) , indicating that LH-releasing hormone/FSH-releasing hormone stimulates cAMP synthesis. 10 mM of theophylline alone led to a 4-fold stimulation of cAMP accumulation during an 80-min incubation period (Fig. 4) . 
Specificity of the Effect of LH-Releasing Hormone/FSH-
Releasing Hormone on Hormonal Release. Fig. 5 shows that the stimulatory effect of synthetic LH-releasing hormone/-FSH-releasing hormone is highly specific for LH and FSH, no effect being detected on the release of adrenocorticotropic hormone, thyrotropin, growth hormone, or prolactin.
DISCUSSION
The availability of synthetic LH-releasing hormone/FSHreleasing hormone (14) (15) (16) opens new possibilities for study of the mechanism of action of this neurohormone in the adenohypophysis. Confirming previous observations made both iF vivo and in vitro (4-8, 10, 13, 42-45) 
